Edward J. Boyko

Edward J. Boyko

Auto-generated profile, based on publicly available information

Edward J. Boyko

Seattle Epidemiologic Research and Information Center, VA Puget Sound Healthcare System, Seattle, Washington, United States of America

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2003 in Diabetologia
Verified
Journal Article
Closed access
PDF file
MCMiriam Cnop
Miriam Cnop
PHPeter Havel
Peter Havel
KUK. M. Utzschneider
K. M. Utzschneider
DCD. B. Carr
D. B. Carr
MSM. K. Sinha
M. K. Sinha
SKS. E. Kahn
S. E. Kahn

1 September 2004
Verified
Journal Article
Closed access
LCLisa D Chew
Lisa D Chew
KBKatharine A Bradley
Katharine A Bradley
EBEdward J Boyko
Edward J Boyko

1 January 2022 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
KOKatherine Ogurtsova
Katherine Ogurtsova
LGLeonor Guariguata
Leonor Guariguata
Noel Christopher BarengoNoel Christopher Barengo
Noel Christopher Barengo
PRPaz Lopez-Doriga Ruiz
Paz Lopez-Doriga Ruiz
JSJulian W. Sacre
Julian W. Sacre
DMDianna Magliano
Dianna Magliano

1 January 1999 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
GRG E Reiber
G E Reiber
LVL Vileikyte
L Vileikyte
EBE J Boyko
E J Boyko
MAM del Aguila
M del Aguila
DSD G Smith
D G Smith
ABA J Boulton
A J Boulton
OBJECTIVE: To determine the frequency and constellations of anatomic, pathophysiologic, and environmental factors involved in the development of incident diabetic foot ulcers in patients with diabetes and no history of foot ulcers from Manchester, U.K., and Seattle, Washington, research settings. RESEARCH DESIGN AND METHODS: The Rothman model of causation was applied to the diabetic foot ulcer condition. The presence of structural deformities, peripheral neuropathy, ischemia, infection, edema, and callus formation was determined for diabetic individuals with incident foot ulcers in Manchester and Seattle. Demographic, health, diabetes, and ulcer data were ascertained for each patient. A multidisciplinary group of foot specialists blinded to patient identity independently reviewed detailed abstracts to determine component and sufficient causes present and contributing to the development of each patient's foot ulcer. A modified Delphi process assisted the group in reaching consensus on component causes for each patient. Estimates of the proportion of ulcers that could be ascribed to each component cause were computed. RESULTS: From among 92 study patients from Manchester and 56 from Seattle, 32 unique causal pathways were identified. A critical triad (neuropathy, minor foot trauma, foot deformity) was present in > 63% of patient's causal pathways to foot ulcers. The components edema and ischemia contributed to the development of 37 and 35% of foot ulcers, respectively. Callus formation was associated with ulcer development in 30% of the pathways. Two unitary causes of ulcer were identified, with trauma and edema accounting for 6 and < 1% of ulcers, respectively. The majority of the lesions were on the plantar toes, forefoot, and midfoot. CONCLUSIONS: The most frequent component causes for lower-extremity ulcers were trauma, neuropathy, and deformity, which were present in a majority of patients. Clinicians are encouraged to use proven strategies to prevent and decrease the impact of modifiable conditions leading to foot ulcers in patients with diabetes.

1 May 1996 in Nature Medicine
Verified
Journal Article
Closed access
MSMichael W. Schwartz
Michael W. Schwartz
EPElaine Peskind
Elaine Peskind
MRMurray Raskind
Murray Raskind
EBEdward J. Boyko
Edward J. Boyko
DPDaniel Porte
Daniel Porte

1 February 2009 in Diabetes Care
Verified
Journal Article
Open access
KUKristina Utzschneider
Kristina Utzschneider
RPRonald L. Prigeon
Ronald L. Prigeon
MFMirjam V. Faulenbach
Mirjam V. Faulenbach
JTJenny Tong
Jenny Tong
DCDarcy B. Carr
Darcy B. Carr
SKSteven E. Kahn
Steven E. Kahn
OBJECTIVE—We sought to determine whether an oral disposition index (DIO) predicts the development of diabetes over a 10-year period. First, we assessed the validity of the DIO by demonstrating that a hyperbolic relationship exists between oral indexes of insulin sensitivity and β-cell function. RESEARCH DESIGN AND METHODS—A total of 613 Japanese-American subjects (322 men and 291 women) underwent a 75-g oral glucose tolerance test (OGTT) at baseline, 5 years, and 10 years. Insulin sensitivity was estimated as 1/fasting insulin or homeostasis model assessment of insulin sensitivity (HOMA-S). Insulin response was estimated as the change in insulin divided by change in glucose from 0 to 30 min (ΔI0–30/ΔG0–30). RESULTS—ΔI0–30/ΔG0–30 demonstrated a curvilinear relationship with 1/fasting insulin and HOMA-S with a left and downward shift as glucose tolerance deteriorated. The confidence limits for the slope of the loge-transformed estimates included −1 for ΔI0–30/ΔG0–30 versus 1/fasting insulin for all glucose tolerance groups, consistent with a hyperbolic relationship. When HOMA-S was used as the insulin sensitivity measure, the confidence limits for the slope included −1 only for subjects with normal glucose tolerance (NGT) or impaired fasting glucose (IFG)/impaired glucose tolerance (IGT) but not diabetes. On the basis of this hyperbolic relationship, the product of ΔI0–30/ΔG0–30 and 1/fasting insulin was calculated (DIO) and decreased from NGT to IFG/IGT to diabetes (P < 0.001). Among nondiabetic subjects at baseline, baseline DIO predicted cumulative diabetes at 10 years (P < 0.001) independent of age, sex, BMI, family history of diabetes, and baseline fasting and 2-h glucose concentrations. CONCLUSIONS—The DIO provides a measure of β-cell function adjusted for insulin sensitivity and is predictive of development of diabetes over 10 years.